Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheuma

Author:   U S Department of Healt Human Services ,  Agency for Healthcare Resea And Quality
Publisher:   Createspace
ISBN:  

9781500354657


Pages:   358
Publication Date:   29 June 2014
Format:   Paperback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $68.61 Quantity:  
Add to Cart

Share |

Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheuma


Add your own review!

Overview

This report is one of several reports focusing on the role of omega-3 fatty acids in the prevention or treatment of various diseases. This report focuses on the effects of omega-3 fatty acids on immune-mediated diseases, bone metabolism, and gastrointestinal/renal diseases. Over the past 40 years, an increasing number of physiological functions have been attributed to omega-3 fatty acids, including movement of calcium and other substances into and out of cells, relaxation and contraction of muscles, inhibition and promotion of clotting, regulation of secretion of substances that include digestive enzymes and hormones, control of fertility, cell division, and growth.1 In addition, omega-3 fatty acids may play an important role in brain development and function. Some evidence has suggested that omega-3 fatty acids in the diet may protect against heart attack and stroke, as well as certain inflammatory diseases like arthritis, lupus, and asthma. The major dietary sources of omega- 3 fatty acids in the U.S. population are fish, fish oil, vegetable oils (principally canola and soybean), walnuts, wheat germ, and some dietary supplements. The following conditions were addressed: Rheumatoid arthritis, systemic lupus erythematosis (SLE), and bone density/osteoporosis; Renal disease and diabetes; Gastrointestinal diseases. The TEPs advised us on refining the preliminary questions posed to us by AHRQ, determining the proper inclusion/exclusion criteria for the study and the populations of interest, establishing the proper outcomes measures, and conducting the appropriate analyses.

Full Product Details

Author:   U S Department of Healt Human Services ,  Agency for Healthcare Resea And Quality
Publisher:   Createspace
Imprint:   Createspace
Dimensions:   Width: 21.60cm , Height: 1.90cm , Length: 27.90cm
Weight:   0.830kg
ISBN:  

9781500354657


ISBN 10:   1500354651
Pages:   358
Publication Date:   29 June 2014
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List